PHARMA WISDOM

Pharma, Life Science, Healthcare, Engineering Job Updates

Recent Updates

Monday, 22 February 2016

PHARMA IKON - 2016 @ CHILKUR BALAJI COLLEGE OF PHARMACY on 5th MARCH 2016 (Abstract Submission Date: 03/05/2016)

17:44:00 0
Abstract submission date has been extended up to 3rd March, 2016 



One Day National Symposium on Recent Developments in Pharmacy

5th MARCH 2016

Organized By

CHILKUR BALAJI COLLEGE OF PHARMACY 
Hyderabad

CONFERENCE HIGHLIGHTS:
The objective of the conference is to create awareness on latest technology and recent trends in Pharmacy. The conference on board area of new techniques is proposed to conduct at our institute for B.Pharm, M.Pharm and Pharm.D students, Faculty & Research Scholars and faculties of various colleges from Telangana, A.P and other states.
• The conference will be delivered by guest faculty who will be drawn from pharmaceutical industry, academia R&D and experienced persons of good repute.
• The objective of the conference is creating an awareness for the pharmacy professionals and stimulate them to contribute for the research and development.
• Will have an opportunity to discuss various research problems with the experts in their field.

PRESENTATION AREAS ON:
• Drug Discovery and Design
• Medicinal Chemistry
• Pharmacognosy & Phytochemistry
• Pharmaceutics & Industrial Pharmacy
• Drug Regulatory Affairs & Intellectual Property Rights
• Pharmacology & Toxicology
• Pharmaceutical Analysis &  Quality Control & Assurance
• Pharma Practice
• Pharmacovigilance

VENUE:
CHILKUR BALAJI  COLLEGE OF PHARMACY,
Near T.S Police Academy, 
Moinadad,
Hyderabad,
Ranga Reddy (Dist) – 500075.
Telangana. 

FEE:
Spot Registration 150/- (Entry Registration for all)
Registration fee includes participation in seminar, conference materials, lunch on conference day.








Read More

Wednesday, 17 February 2016

Invited Application for Ph.D Programme - 2016 Session @ Biju Patnaik University of Technology, Odisha

20:47:00 0


REGISTRATION FOR Ph.D PROGRAMME-2015-16 SESSION

Applications are invited from eligible and interested candidates for registration to the Ph.D. programme in all disciplines of Engineering and Technology, Computer Application, Architecture, Management, Pharmacy, Science and Humanities.

ELIGIBILITY FOR APPLICATION:
All candidates seeking registration to the Ph.D. programmed should possess the requisite qualification as indicated below.
  1. To be eligible for entrance test, a candidate must have obtained a master degree in relevant discipline with a minimum of 6.5 CGPA in a 10 point scale or 60% of marks in aggregate of any recognized University, or any degree recognized as equivalent in the subject in which the candidates wishes to pursue a course or research or in an allied subject.
  2. Candidates having GATE/NET/GPAT/CAT/XAT/QIP or any National level recognized test or having been granted fellowship by recognized organization (such as DST Inspire etc) are exempted from entrance test and they have to appear the Via-Voice of the University.
  3. The candidates having more than 55% and less than 60% marks or equivalent CGPA are also eligible for entrance test subject to having five years of experience in technical institute/R& D laboratories/Industries.

Application form (as per the Appendix-I of Ph.D. regulation) duly filled in should be sent to the Registrar, BPUT, New Campus, Chhend, Rourkela by registered post along with a Demand Draft of Rs. 1000/-(Rupees One Thousand Only) drawn in favour of Biju Patnaik University of Technology, Odisha” on any nationalized bank payable at Rourkela towards processing fee.

Last date for submission of application form: 22.02.2016

The application form can be downloaded from www.bput.ac.in. For all other information candidates are advised to see the website of the University www.bput.ac.in.

Applications received after the due date shall not be considered for scrutiny. Possession of minimum eligibility does not guarantee that the candidate shall be selected for registration.


Read More

Wednesday, 3 February 2016

MICRO LAB Walk-In on 07/02/2016

15:32:00 0

Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations.

Posts: Officer/Executive/Management Trainee

Department: Production/Microbiology/Quality Control

Qualification: B.Pharm/M.Pharm/B.Sc./M.Sc. (Microbiology

Eligibility: Freshers & Experience (2 to 4 years)

Walk-in Date: 07/02/2016

Time: 09:30 a.m. to 02:00 p.m.

Venue: 
MICRO LABS LTD,
113 - 116, KAIDAB
BOMMASANDRA
BANGLORE - 99

Note: only for male candidates

Candidate who are unable to attend interview can send their CV to srinivasam@microlabs.in




Read More

Monday, 1 February 2016

Career as Pharmacists under National Health Mission- Govt Job (591 posts)

22:02:00 0
Online applications are invited for posts of pharmacists on contractual basis under national health mission, Medical and health department by online examination for direct recruitment 2015-16.
This applications will be submitted through states recognized E-mitra kiyosk and common service centre from dated 02.02.2016 by paying service fees. Candidates can fill up application from by themselves from any place but application fees will be accepted by online or cash only through E-mitra kiyosk.
Posts: 
Pharmacist RBSK - No. of posts: 512   
Pharmacists CHC - No. of posts: 79
Ayush Compounder - No. of posts: 150

For above given positions, Reservation will be as per National health mission, Govt of India and state government rules. And merit list will publish as per that.
Applicants min. age should not less than 18 years and max. age should not more than 35 years. Age limit will be considered up to dated 01.01.2016
Last date for filling application fees through E-mitra is 13.02.2016
Last date for filling online application form is 12.02.2016

Read More

Sunday, 31 January 2016

ZIKA VIRUS: What you need to Know..!!!

23:09:00 0


About zika virus History:
The Zika virus is found in tropical locales with large mosquito populations. Outbreaks of Zika virus disease have been recorded in Africa, the Americas, Southern Asia and Western Pacific. The virus was first identified in Uganda in 1947 in rhesus monkeys and was first identified in people in 1952 in Uganda and Tanzania, according to the WHO.

Ten things you should know about Zika virus
Global health officials say the Zika virus, linked to severe birth defects in thousands of babies in Brazil, is spreading rapidly in the Americas and could infect 3 million to 4 million people. The race is on to develop a Zika vaccine.


The World Health Organization said Zika cases have been reported in 23 countries and territories in the Americas in the current outbreak. Brazil has been the nation most affected. Other nations and territories include Barbados, Bolivia, Colombia, Dominican Republic, Ecuador, El Salvador, French Guiana, Guadeloupe, Guatemala, Guyana, Haiti, Honduras, Martinique, Mexico, Nicaragua, Panama, Paraguay, Puerto Rico, Saint Martin, Suriname, Venezuela and the U.S. Virgin Islands, according to the PAHO.




Ten things you should know about Zika virus
The virus is transmitted to people through the bite of infected female Aedes mosquitoes, the same type of mosquito that spreads dengue, chikungunya and yellow fever. The Pan American Health Organization (PAHO) said Aedes mosquitoes are found in all countries in the Americas except Canada and continental Chile, and the virus will likely reach all countries and territories of the region where Aedes mosquitoes are found.


Symptoms:1.About 1 in 5 people infected with Zika virus become ill (i.e., develop Zika).2.The most common symptoms of Zika are fever, rash, joint pain, or conjunctivitis (red eyes). Other common symptoms include muscle pain and headache. The incubation period (the time from exposure to symptoms) for Zika virus disease is not known, but is likely to be a few days to a week.3.The illness is usually mild with symptoms lasting for several days to a week.4.Zika virus usually remains in the blood of an infected person for a few days but it can be found longer in some people.5.Severe disease requiring hospitalization is uncommon.6.Deaths are rare.

Diagnosis:
1.The symptoms of Zika are similar to those of dengue and chikungunya, diseases spread through the same mosquitoes that transmit Zika.
See your healthcare provider if you develop the symptoms described above and have visited an area where Zika is found.
2.If you have recently traveled, tell your healthcare provider when and where you traveled.
3.Your healthcare provider may order blood tests to look for Zika or other similar viruses like dengue or chikungunya.

Treatment:

1. No vaccine or medications are available to prevent or treat Zika infections.
2. Treat the symptoms:
3. Get plenty of rest
4. Drink fluids to prevent dehydration
5. Take medicines, such as acetaminophen or paracetamol, to relieve fever and pain. 
6. Do not take aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs), like ibuprofen and naproxen. Aspirin and NSAIDs should be avoided until dengue can be ruled out to reduce the risk of hemorrhage (bleeding). If you are taking medicine for another medical condition, talk to your healthcare provider before taking additional medication.
7. If you have Zika, avoid mosquito bites for the first week of your illness.
8. During the first week of infection, Zika virus can be found in the blood and passed from an infected person to another mosquito through mosquito bites.
9. There is no treatment or vaccine available for Zika infection. Companies and scientists are racing to develop a safe and effective vaccine for Zika, but one is not expected to be ready for months or years.

The PAHO said there is no evidence that Zika can cause death but some cases have been reported with more serious complications in patients with pre-existing medical conditions. 

The virus has been linked to microcephaly, a condition in newborns marked by abnormally small heads and brains that have not developed properly. It also has been associated with Guillain-Barre syndrome, a rare disorder in which the body's immune system attacks part of the nervous system. Scientists are studying whether there is a causal link between Zika and these two disorders.


People who get Zika virus disease typically have a mild fever, skin rash, conjunctivitis, muscle and joint pain and fatigue that can last for two to seven days. But as many as 80 percent of people infected never develop symptoms. The symptoms are similar to those of dengue or chikungunya, which are transmitted by the same type of mosquito.

The PAHO also said Zika can be transmitted through blood, but this is an infrequent transmission mechanism. There is no evidence the virus can be transmitted to babies through breast milk.






Prevention:
Until more is known, the Ministry of Health recommends that women who are pregnant or plan to become pregnant in the near term consider delaying travel to areas with Zika virus present. If travelling in Zika infected areas, women who are pregnant or plan to become pregnant should consult with their healthcare provider and take all precautions to avoid mosquito bites, including:
  • Wear long-sleeved shirts and long pants
  • Use insect repellents containing DEET, picaridin, oil of lemon eucalyptus (OLE), or IR3535. Always use as directed.
  • Insect repellents containing DEET, picaridin, and IR3535 are safe for pregnant and nursing women and children older than 2 months when used according to the product label. Oil of lemon eucalyptus products should not be used on children under 3 years of age.
  • If you use both sunscreen and insect repellent, apply the sunscreen first and then the repellent.
  • Use permethrin-treate clothing and gear (such as boots, pants, socks, and tents).
  • Use bed nets as necessary
  • Stay and sleep in screened-in or air-conditioned rooms.
If you are pregnant and develop a rash, red eyes, fever, or joint pain within 14 days of travel to a Zika virus infected country, please consult your health care provider and let them know your travel history.
Provisional Remarks ...
The National Health Institute reported that Colombia now has 20,297 cases of Zika infection, including 2,116 in expectant mothers.

Read More

Friday, 29 January 2016

PHARMACY STUDY MATERIAL

14:08:00 3



STANDARDIZATION OF HERBAL DRUGS (Evaluation of Crude Drugs)

PLANT TISSUE CULTURE (Micro-Propagation of Medicinal Plants)

NATURAL DYES

EXTRACTION AND IDENTIFICATION OF PHYTO-CONSTITUENTS

PLANT GROWTH REGULATORS

MARINE DRUGS

PRINCIPLES OF TRADITIONAL SYSTEM OF MEDICATION (TSM)

AYURVEDA (INDIAN TRADITION OF MEDICATION)

NUTRACEUTICALS
Click Here to Download

HERBAL COSMETICS
Click Here to Download

STUDY OF TRADITIONAL DRUGS
Click Here to Download

UNANI SYSTEM OF MEDICATION
Click Here to Download

FATS LIPIDS WAX
Click Here to Download

ADULTERATION OF CRUDE DRUGS
Click Here to Download

NATURAL PESTICIDES
Click Here to Download

PHYTO PHARMACEUTICALS
Click Here to Download

HISTORY OF PHARMACY
Click Here to Download

FACTORS INFLUENCING CULTIVATION OF MEDICINAL PLANTS
Click Here to Download

CULTIVATION, COLLECTION, STORAGE OF CRUDE DRUGS
Click Here to Download

ETHNOBOTANY
Click Here to Download

INTRODUCTION TO PHARMACOGNOSY & SCOPE OF PHARMACOGNOSY
Click Here to Download

GLYCOSIDES
Click Here to Download

ALKALOIDS
Click Here to Download

RESINS
Click Here to Download



ANTI-CANCER DRUGS 
(ANTI-NEOPLASTIC AGENTS)
CHEMOTHERAPY OF CANCER
Click Here to View and Download

ANTI-TUBERCULAR DRUGS
Click Here to Download

CHEMOTHERAPY OF TUBERCULOSIS
Click Here to Download

PENICILLIN
Click Here to Download

ANTI-BIOTICS
Click Here to Download

SULFONAMIDE 
(SULFA DRUGS - ANTI BACTERIAL AGENTS)
Click Here to View


Recombinant DNA (r-DNA) Technology
Click Here to Download

ANTI FUNGAL DRUGS

STEROID HORMONES

ANTI - ARRHYTHMIC DRUGS

Classification and Synthesis of Chemotherapeutic Agents
(Sulpha drugs, Anti-Viral Drugs, Anti-Fungal Agents, Anti -Tubercular Agents, Anti-leprotic Agents, Anti-amoebic Agents, Anthelmintics, Anti-Malarial Drugs, Anti-cancer Drugs)
Click Here to Download



STEREO-CHEMISTRY (3D CHEMISTRY)

STUDY OF FOLLOWING OFFICIAL COMPOUNDS - PHARM.D 1st YEAR
Click Here to View & Download





Read More